Cedar Brook Financial Partners, LLC Eli Lilly & CO Transaction History

Cedar Brook Financial Partners, LLC

$698 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$724.87 - $909.04 $829,251 - $1.04 Million	-1,144 Reduced 73.9%	404 $365,000
Q1 2024 Apr 17, 2024	BUY	$592.2 - $792.28 $39,677 - $53,082	67 Added 4.52%	1,548 $1.2 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $61,972 - $73,057	-118 Reduced 7.38%	1,481 $863,000
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $272,991 - $376,360	-628 Reduced 28.2%	1,599 $858,000
Q2 2023 Jul 05, 2023	BUY	$350.74 - $468.98 $172,213 - $230,269	491 Added 28.28%	2,227 $1.04 Million
Q1 2023 Apr 04, 2023	SELL	$310.63 - $364.82 $12,735 - $14,957	-41 Reduced 2.31%	1,736 $596,000
Q4 2022 Feb 01, 2023	SELL	$321.55 - $374.67 $45,017 - $52,453	-140 Reduced 7.3%	1,777 $650,000
Q3 2022 Jan 03, 2023	SELL	$296.48 - $337.87 $126,004 - $143,594	-425 Reduced 18.15%	1,917 $619,000
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $41,252 - $48,435	-148 Reduced 5.94%	2,342 $759,000
Q1 2022 Apr 06, 2022	SELL	$234.69 - $291.66 $25,346 - $31,499	-108 Reduced 4.16%	2,490 $713,000
Q4 2021 Jan 27, 2022	BUY	$224.85 - $279.04 $76,449 - $94,873	340 Added 15.06%	2,598 $717,000
Q3 2021 Nov 01, 2021	SELL	$221.6 - $272.71 $21,938 - $26,998	-99 Reduced 4.2%	2,258 $522,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $7,944 - $10,275	44 Added 1.9%	2,357 $541,000
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $134,906 - $174,643	821 Added 55.03%	2,313 $432,000
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $14,220 - $18,816	109 Added 7.88%	1,492 $252,000
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $202,222 - $233,906	1,383 New	1,383 $204,000
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $200,368 - $248,173	-1,874 Closed	0 $0
Q3 2019 Oct 24, 2019	BUY	$106.79 - $116.16 $200,124 - $217,683	1,874 New	1,874 $210,000
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $197,760 - $230,836	-1,785 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $198,688 - $233,870	1,785 New	1,785 $232,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.9 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.

Account